explore -WSS

explore

author：leisure time 2025-10-01 00:05:34 - browse：41

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

knowledge

WSS

Keeping primary care docs in field isn't impossible, says AAFP CEO

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Why health care costs have stayed mostly flat since 2010

HHS secretary Becerra pressed on Change HealthCare cyberattack

Virtual care provider acquires bankrupt Pear's prescription apps

How many hemophilia patients actually want gene therapy?

knowledge

explore

leisure time

What does generative AI mean for health care? We asked experts

EPA limits use of carcinogenic gas for sterilizing medical devices

Malaria cases in Florida and Texas: Here’s what you need to know

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Continuity nursing helped my family in our darkest PICU moments

WuXi out of biotech trade group, U.S. and China relations to blame

Cancer drug shortages should be causing more outrage

HCA sued by state AG for quality issues at Mission Health

Anesthesiologist group: stop taking Ozempic before surgery

President Biden's budget: Here's what you might have missed

focus

Violet CEO on training clinicians to promote more inclusive care

What STAT readers think about the FDA and patient advocacy

SEC charges former device maker CEO with $41 million fraud

Keeping primary care docs in field isn't impossible, says AAFP CEO

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Christmas in the PICU brings some surprising joy

knowledge

focus

focus

knowledge